Atlas Trials

Berlin-Chemie AG Menarini Group

8 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Berlin-Chemie AG Menarini Group

RecordFirmDate
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin Hydrochloride 0.4 mg, Prolonged-release Film-coated Tablets, in Healthy Adult Male Subjects, Under Fasting Conditions (NCT07156916)Berlin-Chemie AG Menarini Group2025-09-08
A Comparative Bioavailability Study of Two Torasemide 10 mg Tablets Formulations in Healthy Adult Participants Under Fasting Conditions: (NCT07201584)Berlin-Chemie AG Menarini Group2025-09-05
A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tamsulosin 0.4 mg Tablets, in Healthy Adult Male Subjects, Under Fed Conditions (NCT07091669)Berlin-Chemie AG Menarini Group2025-06-16
A Comparative Bioavalability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®, Tabsulosine 0.4 mg Tablets in Healthy Adult Male Subjects, at Steady State (NCT07146711)Berlin-Chemie AG Menarini Group2025-03-03
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension (NCT07036861)Berlin-Chemie AG Menarini Group2023-11-06
Levothyroxine-sodium Bioequivalence Trial With Oral Single Dose Administration (NCT06547242)Berlin-Chemie AG Menarini Group2021-10-22

Track Berlin-Chemie AG Menarini Group automatically

Every clearance here is in the API, with alerts when new ones post.